Aerie (AERI) September volatility at 190 into 'successful' efficacy results of Phase 3 Roclatan trial
Go back to Aerie (AERI) September volatility at 190 into 'successful' efficacy results of Phase 3 Roclatan trialAERIE PHARMACEUT (NASDAQ: AERI) | Delayed: 15.25 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $15.25 | 52 Week High | $41.72 | |||
Open | $15.25 | 52 Week Low | $10.82 | |||
Day High | $15.25 | P/E | N/A | |||
Day Low | $15.25 | EPS | $-0.95 | |||
Volume | 418,332 |